Dong-A Pharm. Co., Ltd.

Dong-A Pharmaceutical Co., Ltd

Dong-A St Co., Ltd.

Korea University Research and Business Foundation

Soon Hoe Kim

Moohi Yoo

Mi Won Son

Moon-Ho Son

Mi-Kyung Kim

Woo Young Kwak

Heung Jae Kim

Tae Hyun Yoon

Jong Pil Min

Chang Yell Shin

Song-Hyen Choi

Jae Young Lee

Ji Eun Lee

Dae Hwan Kim

Tae Ho Lee

Dong Sung Kim

Sang Deuk Lee

Hyun Wook Kim

Mi Hwa Lee

Geun Jho Lim

Mi Rim Jin

Jae Keol Rhee

Sang Jin Choi

Chong Hwan Cho

Jae Sung Yang

Won Bae Kim

Youngmoon Choi

Choon W Lee

Hee Chan Shin

Byoung Ok Ahn

Joong In Lim

Yu Na Chae

Ik Yon Kim

Kyung Jin Park

Moo Hi Yoo

Eun Kyoung Yang

Tae Young Oh

Sun Woo Jang

Joon Ho Jun

Nam Gi Baik

Moon H Son

Byung Kwon Ryu

Moohi Y Kim

Joon W Kim

Hyun T Shin

Jin Joo Cha

Ji Myun Jang

Nam Joon Baek

Gook Jun Ahn

Hadong Kim

Hae-Sun Kim

Dae Ryong Cha

Yong Sung Sohn

Young Sun Kang

Sang Dug Han

Yong Sam Kwon

Jin Pub Son

Sung Rak Choi

Jung Eun Kim

Tao Ho Lee

The present invention relates to a pharmaceutical composition for forming a film directly on a wound to accelerate wound healing, a use for the same, a treatment method using the same, and a method for preparing the same. The film-forming composition according to the present invention forms a film directly on the wound to increase the adhesion to the wound. The formed thin hydrophilic film protects the wound surface to prevent infection of the wound surface, retains the physiologically active substance useful for wound healing on the wound surface to promote the wound healing, and allow drugs to be continuously delivered to the wound surface. Therefore, the composition according to the present invention has excellent wound healing effect and has excellent usability as it is not absorbed into clothing, bandage, etc., thus effectively replacing conventional gel or ointment formations for delivering physiologically active substances.

Film-forming pharmaceutical composition for wound healing and method for preparing the same

The present invention relates to a composition for preventing or treating renal diseases. The composition of the present invention improves lipid metabolism, prevents histological damage including renal fibrosis, alleviates microalbuminuria, and maintains nephrons of renal glomeruli. Therefore, the composition is useful for treating renal diseases.

Composition containing a DPP-IV inhibitor for preventing or treating renal diseases

The present invention relates to herbal extracts ofSemen,Tuber,Seed, andSemen, and a composition containing the same for treating and preventing gastrointestinal motility disorder. The extracts of the present invention have a remarkable effect of promoting gastrointestinal motility through HTreceptor antagonism and/or HTreceptor antagonism.

Extract of herbal and composition containing the same

The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a compound which inhibits the activity of dipeptidyl peptidase-IV (DPP-IV), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and one or more other antidiabetic or antiobesity agents. The pharmaceutical composition exhibits excellent glucose tolerance and may be useful in the prevention and treatment of diabetes, obesity, and the like by effectively inhibiting blood glucose levels and reducing fat mass.

Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients

The present invention provides a novel heterocyclic compound containing a beta-amino group, a method for preparing the same, and a pharmaceutical composition comprising the same heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient. The heterocyclic compound of the present invention exhibits excellent DPP-IV inhibitory activity and bioavailability and therefore can be useful for the prophylaxis or treatment of DPP-IV-related diseases such as diabetes or obesity.

DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity

Gastroprotective flavone/flavanone compounds with therapeutic effect on

A benzoxazine or benzothiazine derivative of the formula (A), ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and represent a hydrogen atom or a C.sub.1-4 alkyl group; or R.sub.1 and R.sub.2 can be joined together along with the imidazole ring to form a benzimidazole; X and Y are the same or different and represent an oxygen or sulfur atom; or a pharmaceutically acceptable salt thereof, exhibits an excellent inotropic effect and can be used as a cardiac stimulant.

Imidazole substituted benzoxazine or benzothiazine derivatives

Growing community of inventors

Suwon-si, South Korea

Soon Hoe Kim